First Human Trial of Targeting MDM2/MDMX PET Imaging

NCT06443762 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

MDM2/MDMX Gene Mutation
Nuclear Medicine
Positron Emission Tomography Imaing

Interventions

DRUG: [68Ga] MDM2/MDMX Peptide

Sponsor

Peking University Cancer Hospital & Institute